
The report from the accounting judiciary highlights staff shortages, territorial gaps and problems in the use of funds
Waiting lists remain a structural criticality of Italian healthcare, marked by staff shortages, territorial differences and problems in the use of funds, according to the report by the Court of Auditors.
AI-generated summary
The Court of Auditors analyzed the implementation of measures to reduce healthcare waiting lists between 2022 and 2028.
Waiting lists continue to represent "a structural criticality of the Italian healthcare system", linked not only to the effects of the pandemic, but also to organisational, management and planning factors.
Despite the strengthening of the regulatory and financial framework "implementation difficulties, staff shortages and territorial differences persist which limit the effectiveness of the interventions". The Court of Auditors states this in the report on "The implementation of measures aimed at reducing waiting lists", also underlining that "the increase in funding has not always produced proportionate results in terms of services provided and reduction of waiting times".
In the period 2022-2028, the resources allocated to containing waiting lists amount to approximately 3.71 billion euros, while in the four-year period 2022-2025, according to data from the Ministry of Health, against state allocations amounting to approximately 1.845 billion euros, approximately 1.58 billion were used, underlines the Court.
"The lack of completeness and uniformity of the information transmitted by the Regions, however, makes a precise evaluation of the use of the funds and the results achieved difficult", it is highlighted.
In this context, the measures introduced by Legislative Decree 73 of 2024 outline a new governance model, based on the strengthening of control systems, digitalisation and the timely availability of data. A system which, according to the accounting judiciary, "could favor a structural improvement of the system, the effects of which can be fully assessed only after the full implementation of the planned interventions".
From the National Waiting List Platform (Pnla), "particularly relevant for the interoperability of regional systems and the availability of comparable data, critical issues emerge in the regional use of the 'P' (scheduled) priority class, differences between the appointment dates proposed and those accepted by citizens, as well as delays between the prescription and the first contact with the CUP and gaps between the prescriptions issued and the bookings registered".
The analysis confirms "difficulties in expanding the healthcare offer, even in the presence of adequate financial resources, due to the shortage of personnel, especially specialists, and therefore recalls the need to complete the reform of local assistance envisaged by the Pnrr and by Ministerial Decree no. 77 of 2022, to improve care, reduce improper demand and lighten the pressure on hospital structures and specialist services".
The accounting judiciary therefore recommends accelerating the implementation of the 2024 decree, completing the interoperability of the Pnla, strengthening control over the use of resources and the results obtained, improving the planning of care needs and adopting structural interventions to overcome staff shortages.
For the Court, "it is also necessary to make the accountability mechanisms more effective, promptly identifying non-compliances, applying the foreseen sanctions and exercising, when the relevant conditions are met, the substitutive powers".
A lasting reduction in waiting times and timely and equitable access to healthcare services "require - concludes the document - transparency, continuous monitoring, institutional responsibility, efficient use of resources and timely reporting of results".

Waiting lists remain a structural criticality of Italian healthcare, between staff shortages and territorial gaps, according to the Court of Auditors.

Waiting lists remain a structural criticality of Italian healthcare, between staff shortages and territorial differences, according to the Court of Auditors.

Italian authorities are warning of a new wave of phishing scams that exploit fake email and text messages, apparently coming from the Ministry of Health and the Revenue Agency, to trick users into entering personal and banking details on cloned websites, with risks of document cloning and financial fraud.
In-depth study on psoriatic arthritis and mental health: the need for early diagnoses for rheumatic pathology and the alarming data of the global increase in mental disorders among young people.

In Italy, in 2024, around 430 thousand children under 16 (5.6%) live in families that have to give up adequate nutrition or social activities such as inviting friends home, according to the ActionAid report on food poverty. Among children aged 6-11 years, the percentage rose from 3.8% in 2021 to 6.8% in 2024, with around 90 thousand more cases. The report is based on Eu-Silc, FAO Fies and Istat data, analyzing the DAMS index on material and/or social food deprivation.

The European Medicines Agency has recommended marketing authorization for daraxonrasib, a tablet medicine already approved in the United States for the treatment of metastatic pancreatic cancer, citing significant improvements in survival. The final decision now rests with the European Commission.